Stefan Mockenhaupt von HOFFMANN EITLE

Stefan Mockenhaupt

Dr. rer. nat., Dipl.-Biotech., German and European Patent Attorney Languages DE | EN | FR | ES Biotechnology Team Encrypted E-mail to Stefan Mockenhaupt

more information


T +49 89 92 40 90

Arabellastraße 30
81925 München

Creative solutions for your biotech IP

As an associate in the biotechnology practice group, Stefan Mockenhaupt’s practice covers a broad mixture of biotechnological applications, including microbiological production methods, diagnostics, stem cells and biological drugs. He has particular expertise with patenting nucleic acid- and antibody-based therapeutics and gene therapy at all stages of drug development, covering broad “platform” technologies, concrete therapeutics, as well as specific medical uses and formulation claims.

Stefan’s work at HOFFMANN EITLE involves the entire life cycle of a patent, including drafting new applications in close collaboration with the clients, patent prosecution, as well as opposition and appeal proceedings at the EPO. He also oversees and coordinates the national phase prosecution in numerous patent families across the globe.

Stefan is dedicated to combining his professional experience with an open and creative mind to meet the unique requirements of each individual case and find the optimum solution for each client.

Prior to joining HOFFMANN EITLE in 2016, Stefan completed his training as biotechnologist in a joint trinational study program of the Universities of Freiburg, Basel, Karlsruhe and Strasbourg and obtained his doctoral degree from the University of Heidelberg. He then moved to Singapore as post-doctoral researcher at Nanyang Technological University (NTU). Through his studies and diverse research activities, Stefan has profound technical knowledge across the whole spectrum of biotechnology, ranging from industrial microbiology over yeast genetics to human gene therapy, with a focus on viral vector-mediated gene therapy, RNAi and genome engineering.

In his spare time, Stefan is a passionate Jazz Manouche guitarist and enjoys hiking in the nearby mountains with his family.

Professional Membership
show more
  • German Patent Attorney Bar Association
  • epi
Academic Degrees
show more
  • Dr. rer. nat., Heidelberg University
  • Diploma (equivalent to MSc) in Biotechnology, École Supérieure de Biotechnologie Strasbourg (ESBS)
show more
  • German Patent Attorney
  • European Patent Attorney
show more
  • Senís E, Mockenhaupt S, Rupp D, Bauer T, Paramasivam N, Knapp B, Gronych J, Grosse S, Windisch MP, Schmidt F, Theis FJ, Eils R, Lichter P, Schlesner M, Bartenschlager R, Grimm D. TALEN/CRISPR-mediated engineering of a promoterless anti-viral RNAi hairpin into an endogenous miRNA locus. 2017, Nucleic Acids Res;45(1):e3
  • Michler T, Große S, Mockenhaupt S, Röder N, Stückler F, Knapp B, Ko C, Heikenwalder M, Protzer U, Grimm D. Blocking sense-strand activity improves potency, safety and specificity of anti-hepatitis B virus short hairpin RNA. 2016, EMBO Mol Med;8(9):1082-98
  • Mockenhaupt S, Makeyev E. Non-coding functions of alternative pre-mRNA splicing in development. 2015, Semin Cell Dev Biol, 47-48:32-9
  • Mockenhaupt S, Grosse S, Rupp D, Bartenschlager R, Grimm D. Alleviation of off-target effects from vector-encoded shRNAs via co-delivered RNA decoys. 2015, Proc Natl Acad Sci USA 112(30):E4007-16
  • Börner K, Niopek D, Cotugno G, Kaldenbach M, Pankert T, Willemsen J, Zhang X, Schürmann N, Mockenhaupt S, Serva A, Hiet MS, Wiedtke E, Castoldi M, Starkuviene V, Erfle H, Gilbert DF, Bartenschlager R, Boutros M, Binder M, Streetz K, Kräusslich HG, Grimm D. Robust RNAi enhancement via human Argonaute-2 overexpression from plasmids, viral vectors and cell lines. 2013, Nucleic Acids Res 41(21):e199
  • Mockenhaupt S, Börner K, Grimm D. Perturbation of the cellular RNAi machinery in disease and therapy: Lessons learned and avenues paved. 2011, DGZ Cell News 2:8-16
  • Niopek D, Berrens R, Mockenhaupt S, Lewis MD, Mueller AK, Grimm D. To go, or not to go, that is the question - six personal reflections on how geographic mobility may affect your career and life. 2011, Bioessays 33(10):728-31
  • Mockenhaupt S, Schürmann N, Grimm D. When cellular networks run out of control: global dysregulation of the RNAi machinery in human pathology and therapy. 2011, Prog Mol Biol Transl Sci 102:165-242